These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Open trial study of a combined antidepressant (amitryptiline, perphenazine, diazepam) versus fluoxetine or imipramine in ambulatory depressed patients. Diaz A, Fouilloux C, Ortiz S. Proc West Pharmacol Soc; 2002 Nov; 45():154-5. PubMed ID: 12434564 [No Abstract] [Full Text] [Related]
8. Tricyclic antidepressant concentrations in plasma: an estimate of their sensitivity and specificity as a predictor of response. Perry PJ, Zeilmann C, Arndt S. J Clin Psychopharmacol; 1994 Aug; 14(4):230-40. PubMed ID: 7962678 [Abstract] [Full Text] [Related]
15. Comparison of the cardiovascular toxicity of three tricyclic antidepressant drugs: imipramine, amitriptyline, and doxepin. Brown TC, Leversha A. Clin Toxicol; 1979 Mar; 14(3):253-6. PubMed ID: 455914 [Abstract] [Full Text] [Related]
16. The Pisa syndrome (pleurothotonus) during antidepressant therapy. Suzuki T, Kurita H, Hori T, Sasaki M, Baba A, Shiraishi H, Piletz JE. Biol Psychiatry; 1997 Jan 15; 41(2):234-6. PubMed ID: 9018396 [No Abstract] [Full Text] [Related]
19. A new antidepressant agent: amitriptyline-N-oxide. Borromei A. Adv Biochem Psychopharmacol; 1982 Jan 15; 32():43-7. PubMed ID: 7046367 [No Abstract] [Full Text] [Related]
20. Dopamine autoreceptor subsensitivity: a mechanism common to the treatment of depression and the induction of amphetamine psychosis. Antelman SM, Chiodo LA. Biol Psychiatry; 1981 Aug 15; 16(8):717-27. PubMed ID: 7197169 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]